![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Chromogenex | LSE:CGX | London | Ordinary Share | GB00B0B7XX32 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.325 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 9981Z Chromogenex PLC 28 July 2008 Chromogenex plc (the 'Company) FDA approval for the Chromolite EP Chromogenex Plc ('the Company') is pleased to announce that it has now received Section 510(K) approval from the Food and Drug Administration to market and sell its Chromolite EP ( Enhanced Pulse), the newest version of Chromolite, in the United States. Chromolite EP is a state-of-the-art Intense Pulsed Light System used for the treatment of unwanted hair, photo rejuvenation and active acne. Chromolite EP is specially designed for use within a clinic or medspa environment in a single portable device. Peter McGuinness, Chairman, commented: "We are delighted to have received FDA approval for our latest version of the Chromolite product. With the US currently accounting for approximately 50 per cent of the world healthcare market and the Chromolite representing approximately 40 per cent. of the Company's sales, this is a significant achievement in helping drive further revenues for the Company." Chromogenex PLC Tel: +44 20 8434 0540 Peter McGuinness, Chairman HB Corporate Luke Cairns Tel: +44 (0)20 7510 8600 Threadneedle Communications Graham Herring/Alex White Tel: +44 (0)20 7936 9605 This information is provided by RNS The company news service from the London Stock Exchange END MSCFKFKBKBKDAOB
1 Year Chromogenex Chart |
1 Month Chromogenex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions